
Maxmillian Mpina
researcher0.0Global Dominance: 0.00%
Maxmillian Mpina is a co-researcher at the Ifakara Health Institute who played a key role in the development and testing of the SUM-101 malaria vaccine, which has shown promising results in early trials, potentially transforming malaria prevention strategies in sub-Saharan Africa.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Maxmillian Mpina is a lead co-author of the study on the new malaria vaccine SUM-101.
New Tanzanian Malaria vaccine shows strong immune response in early trialsThe Citizen – major Tanzanian English newspaper, est. 2004·
Tanzania· 2025-11-09


